1. Home
  2. RMD vs WTW Comparison

RMD vs WTW Comparison

Compare RMD & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • WTW
  • Stock Information
  • Founded
  • RMD 1989
  • WTW 1828
  • Country
  • RMD United States
  • WTW United Kingdom
  • Employees
  • RMD N/A
  • WTW N/A
  • Industry
  • RMD Medical/Dental Instruments
  • WTW Specialty Insurers
  • Sector
  • RMD Health Care
  • WTW Finance
  • Exchange
  • RMD Nasdaq
  • WTW Nasdaq
  • Market Cap
  • RMD 35.7B
  • WTW 31.5B
  • IPO Year
  • RMD 1995
  • WTW N/A
  • Fundamental
  • Price
  • RMD $232.23
  • WTW $330.89
  • Analyst Decision
  • RMD Buy
  • WTW Buy
  • Analyst Count
  • RMD 12
  • WTW 11
  • Target Price
  • RMD $249.56
  • WTW $333.09
  • AVG Volume (30 Days)
  • RMD 896.1K
  • WTW 572.6K
  • Earning Date
  • RMD 04-24-2025
  • WTW 04-24-2025
  • Dividend Yield
  • RMD 0.91%
  • WTW 1.11%
  • EPS Growth
  • RMD 40.24
  • WTW N/A
  • EPS
  • RMD 8.47
  • WTW N/A
  • Revenue
  • RMD $4,926,773,000.00
  • WTW $9,930,000,000.00
  • Revenue This Year
  • RMD $10.05
  • WTW N/A
  • Revenue Next Year
  • RMD $7.39
  • WTW $5.33
  • P/E Ratio
  • RMD $27.44
  • WTW N/A
  • Revenue Growth
  • RMD 9.38
  • WTW 4.71
  • 52 Week Low
  • RMD $172.19
  • WTW $245.04
  • 52 Week High
  • RMD $263.05
  • WTW $344.14
  • Technical
  • Relative Strength Index (RSI)
  • RMD 47.72
  • WTW 53.60
  • Support Level
  • RMD $219.68
  • WTW $321.31
  • Resistance Level
  • RMD $236.44
  • WTW $344.14
  • Average True Range (ATR)
  • RMD 5.71
  • WTW 5.23
  • MACD
  • RMD -0.40
  • WTW -0.13
  • Stochastic Oscillator
  • RMD 61.74
  • WTW 44.19

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About WTW Willis Towers Watson Public Limited Company

In January 2016, Towers Watson and Willis Group merged to form Willis Towers Watson, a global advisory, insurance brokerage, and solutions company. The company operates in two business segments: health, wealth, and career (its consulting operations) and risk and brokering (its brokerage operations). It has about 48,000 employees.

Share on Social Networks: